Literature DB >> 7078286

The interaction among the criteria physicians use when prescribing.

R N Zelnio.   

Abstract

A randomly selected sample of Iowa physicians was surveyed using a self-administered mail questionnaire that measured the relative importance of prescribing criteria as well as selected physician and practice characteristics. Based on a response rate 68.3 per cent, it was found that the physicians' criteria for selection of a drug to prescribe could be reduced to two groups. The first group is used to select the generic drug or therapeutic class and is of primary concern to the physicians. Those criteria used in specifying a brand of drug product are of lesser importance to physicians and constitute the second group. It was further discovered that physicians could be segregated into two distinct segments based on the importance of the prescribing criteria. It was not possible, however, to explain the composition of the groups using the physician and practice characters measured.

Mesh:

Year:  1982        PMID: 7078286     DOI: 10.1097/00005650-198203000-00004

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  6 in total

1.  Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees.

Authors:  A Anell; P Svarvar
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

2.  Do physicians' perceptions of drug costs influence their prescribing?

Authors:  M Ryan; B Yule; C Bond; R J Taylor
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

3.  Do physicians take cost into account when making prescribing decisions?

Authors:  P Denig; F M Haaijer-Ruskamp
Journal:  Pharmacoeconomics       Date:  1995-10       Impact factor: 4.981

Review 4.  Therapeutic decision making of physicians.

Authors:  P Denig; F M Haaijer-Ruskamp
Journal:  Pharm Weekbl Sci       Date:  1992-02-21

5.  Access to new medications to treat schizophrenia.

Authors:  Tami L Mark; Riad Dirani; Eric Slade; Patricia A Russo
Journal:  J Behav Health Serv Res       Date:  2002-02       Impact factor: 1.505

6.  Lost cost savings to the NHS in England due to the delayed entry of multiple generic low-dose transdermal buprenorphine: a case scenario analysis.

Authors:  Stephen Robert Chapman; Mohammed Ibrahim Aladul; Raymond William Fitzpatrick
Journal:  BMJ Open       Date:  2019-08-01       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.